Statement on use of apolipoprotein E testing for Alzheimer disease

JAMA

Volumn 274, Issue 20, 1995, Pages 1627-1629

  Farrer, Lindsay ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0028889485     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.1995.03530200063039     Document Type: Review

References (55)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-945.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
3. Risse SC, Raskind MA, Nochlin D, et al. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease. Am J Psychiatry. 1990;147:168-172.
4. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol. 1988;24:50-56.
5. Berg L, Morris JC. Diagnosis. In: Terry RD, Katzman R, Bick K, eds. Alzheimer Disease. New York, NY: Raven Press Inc; 1994:9-21.
6. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
7. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. JAMA. 1994;272:1666-1671.
8. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with lateonset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
9. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E allele 4 is associated with dementia in a population based study: the Framingham Study. Neurology. In press.
10. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Liped Res. 1987;28:371-380.
11. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interaction of apolipoprotein E genotype, total cholesterol level, and sex in prediction of Alzheimer disease in a case-control study. Neurology. 1995;45:1092-1096.
12. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol. 1994;53:429-437.
13. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
14. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
15. Chartier-Harlin M-C, Parfitt M, Legrain S, et al. Apolipoprotein E, ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3:569-574.
16. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoe e2. Lancet. 1994;343:1432-1433.
17. Smith AD, Johnston C, Sim E, Nagy Z, Jobst KA, Hindley M, King E. Protective effect of apoE e2 in Alzheimer's disease. Lancet. 1994;344:473-474.
18. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 1994;177:100-102.
19. van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.
20. Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet. 1994;343:1564-1565.
21. Rebeck GW, Peris TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ∈4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 1994;44: 1513-1616.
22. Kuusisto J, Koivisto K, Kervinen Mykkänen L, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994;309:636-638.
23. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol. 1994;36:889-895.
24. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278.
25. Goate A, Chartier-Harlin M-C, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704-706.
26. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in earlyonset familial Alzheimer's disease. Nature. 1995;375: 754-760.
27. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
28. Pickering-Brown SM, Mann DMA, Bourke JP. Apolipoprotein ∈4 and Alzheimer's disease pathology in Lewy body disease and other amyloid forming diseases. Lancet. 1994;343:1155.
29. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ∈4 is overrepresented in patients with the Lewy body variant of Alzheimer disease. Neurology. 1994;44:1950-1951.
30. Betard C, Robitaille Y, Gee M, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovaseular disease and vascular dementia. NeuroReport. 1994;5: 1893-1896.
31. Lippa CF, Smith TW, Saunders AM, et al. Apolipoprotein E genotype and Lewy body disease. Neurology. 1995;45:97-103.
32. Schneider JA, Gearing M, Robbins RS, de l'Aune W, Mirra SS. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol. 1995;38: 131-135.
33. Farrer LA, Abraham CR, Volicer L, et al. Allele ∈4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp Neurol. In press.
34. Shimano H, Murase T, Ishibashi S. Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis. 1989;79:257-260.
35. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240-242.
36. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psych. 1994;57:1414-1416.
37. Lannfelt L, Lilius L, Nastase M, et al. Lack of association between apolipoprotein E allele ∈4 and sporadic Alzheimer's disease. Neurosci Lett. 1994; 169:175-178.
38. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett. 1995;183:32-34.
39. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein-E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254-259.
40. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 1995;37:118-120.
41. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
42. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991;49:338-349.
43. Kamboh MI, Sepehrnia B, Ferrell RE. Genetic studies of human apolipoproteins, VI: common polymorphism of apolipoprotein E in blacks. Dis Markers. 1989;7:49-55.
44. Sepehrnia B, Kamboh MI, Adams-Campbell LL, et al. Genetic studies of human apolipoproteins, X: the effect of apolipoprotem E polymorphism on quantitative levels of lipoproteine in Nigerian blacks. Am J Hum Genet. 1989:45:586-591.
45. Sandholzer C, Delport R, Vermnaak H, Utermann G. High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Hum Genet. 1995;95: 46-48.
46. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein ∈4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994; 7:74-78.
47. Jarvik GP, Wijsman EM. Alzheimer's disease and the family effect. Nat Genet. 1994;8:115.
48. Farrer LA, Cupples LA, van Duijn CM, et al. ApoE genotype in patients with Alzheimer disease: implications for the risk of dementia among relatives. Ann Neurol. In press.
49. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet. 1995;10:486-488.
50. Okuizumi K, Onodera O, Namba Y, et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet. 1995;11:207-209.
51. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol. 1995;38:6-14.
52. Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol. 1995;38:2-4.
53. van Gool WA, Hijdra A. Diagnosis of Alzheimer's disease by apolipoprotein E genotyping. Lancet. 1994; 344275.
54. Farrer LA, Cupples LA, van Duijn CM, Connor-Lacke L, Kiely DK, Growdon JH. Rate of progression of Alzheimer disease is associated with genetic risk. Arch Neurol. 1995;52:918-923.
55. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995;45:1323-1328.